• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Employee Development

Description: Develop and Implement Training Program for Regulatory Counsels in Divisions of Regulatory Policy

Accomplishment: The Office of Regulatory Policy provides CDER oversight and leadership in the development of regulations, policies and procedures that affect the drug approval process, and in the development of new legislation. ORP is also responsible for responding to citizen petitions and FOIA (Freedom of Information Act) requests. The training curriculum was developed to ensure that the staff was knowledgeable about the processes for the completion of tasks, and to maintain operational effectiveness and efficiency. Training was mandatory for ORP staff and completed in the desired timeframe. Training will be repeated at appropriate intervals and the curriculum will be updated periodically.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Finalize training curriculum


Completed 4/30/2010

2. Develop training module 1


Completed 6/25/2010

3. Develop training module 2


Completed 9/22/2010

4. Conduct training session


Completed 9/29/2010

5. Develop training module 3


Completed 11/24/2010

6. Conduct next training session


Completed 12/3/2010

7. Develop training module 4


Completed 3/31/2011

8. Conduct next training session


Completed 3/31/2011

9. Evaluate training curriculum


Completed 3/31/2011

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.